| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 5.997 | 1.825 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 6.001 | 1.829 | 0 | 0 | - |
| Total Expenses - EUR | 1.006 | 902 | 1.365 | 796 | 643 | 563 | 1.084 | 277 | 1.078 | - |
| Gross Profit/Loss - EUR | -1.006 | -902 | -1.365 | -796 | -643 | 5.439 | 746 | -277 | -1.078 | - |
| Net Profit/Loss - EUR | -1.006 | -902 | -1.365 | -796 | -643 | 5.259 | 691 | -277 | -1.078 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Diamedirom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 759 | 809 | 825 | 766 | 741 | 1.483 | 133 | 185 | 155 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 573 | 593 | 608 | 633 | 649 | 1.230 | 76 | 99 | 12 | - |
| Cash | 187 | 215 | 217 | 133 | 92 | 253 | 57 | 87 | 144 | - |
| Shareholders Funds | -28.104 | -28.719 | -29.599 | -29.851 | -29.915 | -24.090 | -22.864 | -23.212 | -24.220 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 28.863 | 29.528 | 30.423 | 30.617 | 30.656 | 25.573 | 22.997 | 23.397 | 24.375 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Diamedirom Srl